Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

L.b. Foster Posts 51% EBITDA Jump in Q2
L.b. Foster Posts 51% EBITDA Jump in Q2

L.b. Foster (NASDAQ:FSTR), a key player in infrastructure and technology-driven solutions for rail and construction markets, reported earnings for Q2 2025 on August 11, 2025. The most important

US Cellular EPS Jumps 80 Percent in Q2
US Cellular EPS Jumps 80 Percent in Q2

United States Cellular (NYSE:USM), Now solely a tower operator following the sale of its wireless operations to T-Mobile, delivered its second quarter earnings release on August 11, 2025. The

Which Four Questions Should You Ask Before Retiring in a Bear Market?
Which Four Questions Should You Ask Before Retiring in a Bear Market?

Whether you're actively planning for retirement or simply dreaming of the day you can retire, you probably have questions. For example, you may wonder how much you must save to retire in style. You

Aaon Posts 65 Percent EPS Drop in Q2
Aaon Posts 65 Percent EPS Drop in Q2

Aaon (NASDAQ:AAON), a leading manufacturer of heating, ventilation, and air conditioning (HVAC) equipment, reported earnings for Q2 2025 on August 11, 2025. The results highlighted operational

Agenus Posts 48% Q2 Revenue MissPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Agenus Posts 48% Q2 Revenue Miss

Agenus (NASDAQ:AGEN), a clinical-stage biotechnology company focused on developing cancer immunotherapies, reported its second quarter 2025 earnings on August 11, 2025. The company's revenue (GAAP)

If You'd Invested $1,000 in Ethereum (ETH) 10 Years Ago, Here's How Much You'd Have Today
If You'd Invested $1,000 in Ethereum (ETH) 10 Years Ago, Here's How Much You'd Have Today

The Ethereum (CRYPTO: ETH) blockchain went live 10 years ago. If you'd invested $1,000 in Ethereum at that time when it was trading at $2.79, you could have bought about 358 ETH tokens. Your

Late to Retirement Planning? 4 Strategies to Help You Catch Up to Your Peers
Late to Retirement Planning? 4 Strategies to Help You Catch Up to Your Peers

If you're late to retirement planning, beating yourself up about it accomplishes nothing. As someone who's had to start over more than once, I'm here to tell you that it's possible, and the further

Village Farms Sales Jump 12 Percent
Village Farms Sales Jump 12 Percent

Village Farms International (NASDAQ:VFF), a diversified greenhouse grower and international cannabis producer, reported GAAP results for Q2 2025 on August 11, 2025. The company posted GAAP earnings

Kymera Revenue Drops 55 Percent in Q2
Kymera Revenue Drops 55 Percent in Q2

Kymera Therapeutics (NASDAQ:KYMR), a biotechnology company recognized for its targeted protein degradation technology, released its second quarter 2025 results on August 11, 2025. The most notable

Immunovant Posts 34% R&D Jump in Q1Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Immunovant Posts 34% R&D Jump in Q1

Immunovant (NASDAQ:IMVT), a clinical-stage biotechnology company focused on therapies for autoimmune conditions, reported results for the quarter ended June 30, 2025, on August 11, 2025. Net loss

Humacyte Posts Q2 Revenue Miss
Humacyte Posts Q2 Revenue Miss

Humacyte (NASDAQ:HUMA), a regenerative medicine company focused on bioengineered human tissues, released its Q2 FY2025 earnings on August 11, 2025. The most notable news from the release was the

Intermex Posts Mixed Results in Q2
Intermex Posts Mixed Results in Q2

International Money Express (NASDAQ:IMXI), a leading provider of money transfer services primarily between the United States and Latin America, reported results for Q2 2025 on August 11, 2025. The

AMC Posts 36 Percent Revenue Jump in Q2Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
AMC Posts 36 Percent Revenue Jump in Q2

AMC Entertainment (NYSE:AMC), a leading movie theater operator, released its second quarter 2025 earnings on August 11, 2025. The company delivered a strong recovery, reporting GAAP revenue of

Better Artificial Intelligence Stock: ASML vs. AMDPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Better Artificial Intelligence Stock: ASML vs. AMD

Artificial intelligence (AI) remains a hot area to invest in, as seen in Nvidia's share price, which is up over 30% this year through Aug. 6. Two AI businesses to consider are ASML Holding (NASDAQ:

Harvard Bioscience Tops Q2 Revenue ViewsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Harvard Bioscience Tops Q2 Revenue Views

Harvard Bioscience (NASDAQ:HBIO), a provider of specialized laboratory technologies for biomedical and life sciences research, released its financial results for the second quarter of fiscal 2025 on

Compass Therapeutics Posts Wider Q2 Loss
Compass Therapeutics Posts Wider Q2 Loss

Compass Therapeutics (NASDAQ:CMPX), a clinical-stage biotechnology company focused on developing novel bispecific antibody therapies for cancer, released its second quarter results on August 11

1 Reason to Buy Berkshire Hathaway (BRK.A) StockPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
1 Reason to Buy Berkshire Hathaway (BRK.A) Stock

Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is one of the world's largest and most successful companies. Led by visionary investor and CEO Warren Buffett since 1965, the investment conglomerate

Excelerate Energy EPS Jumps 31 Percent
Excelerate Energy EPS Jumps 31 Percent

Excelerate Energy (NYSE:EE), a leading provider of Floating Storage and Regasification Units (FSRUs) and integrated LNG solutions, released its earnings for the second quarter of fiscal 2025 on

Owens and Minor Misses Fiscal Q2 Targets
Owens and Minor Misses Fiscal Q2 Targets

Owens & Minor (NYSE:OMI), a leading health care logistics and home health product distribution provider, reported its second quarter 2025 earnings on August 11, 2025. The most notable news was the

1 Reason to Buy EPR Properties (EPR)
1 Reason to Buy EPR Properties (EPR)

EPR Properties (NYSE: EPR) is a real estate investment trust, or REIT, that focuses exclusively on experiential properties. In its portfolio of more than 300 properties are movie theaters, "eat and

The SEC Wants to Supercharge Super-Apps. Here's What Investors Need to Know
The SEC Wants to Supercharge Super-Apps. Here's What Investors Need to Know

Paul Atkins, chairman of the Securities and Exchange Commission (SEC), has unveiled a host of new initiatives under the umbrella of Project Crypto. He says he wants to modernize the SEC's rules and

Here's How Much a $50-Per-Week Investment in the Nasdaq-100 Could Grow to Be Worth in 10, 20, and 30 YearsPhoto, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
Here's How Much a $50-Per-Week Investment in the Nasdaq-100 Could Grow to Be Worth in 10, 20, and 30 Years

The Nasdaq is home to many of the best growth stocks in the world. But an even more exclusive club is the Nasdaq-100 index, which tracks the most valuable stocks on the exchange (excluding financial

Is Wolfspeed a Buy?Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Is Wolfspeed a Buy?

Shares of Wolfspeed (NYSE: WOLF) are down 98% since the company began trading under the WOLF ticker in 2021. The company is working with creditors to restructure its massive debt through the Chapter

RadNet Posts Record Q2 Revenue Up 8%Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
RadNet Posts Record Q2 Revenue Up 8%

RadNet (NASDAQ:RDNT), a major operator of outpatient diagnostic imaging centers, published its second quarter 2025 results on August 11, 2025. The company reported record revenue of $498.2 million

If You'd Invested $1,000 in Progressive Stock (PGR) 10 Years Ago, Here's How Much You'd Have TodayPhoto, wide shot, wide-angle lens, soft focus,  Reinsurance company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-bSRc7PrRT00tZTDNf9SggMTD.png?st=2023-05-06T18%3A48%3A49Z&se=2023-05-06T20%3A48%3A49Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A38%3A49Z&ske=2023-05-07T00%3A38%3A49Z&sks=b&skv=2021-08-06&sig=3seGuy7NQJX9RXUOWr6XArANokWXlKqwnEJxEHfdbSY%3D
If You'd Invested $1,000 in Progressive Stock (PGR) 10 Years Ago, Here's How Much You'd Have Today

Lots of people are probably not interested in how an investment in shares of the Progressive (NYSE: PGR) insurance company has performed over time. They should be, though, because the stock has been